Virginia
Provider Communications
Anthem Blue Cross and Blue Shield local precertification change in Virginia for PPO
Precertification responsibility: The ordering or rendering provider of service is responsible for completing the precertification process.
HMO plans: Services that require precertification will be denied if rendered without the appropriate precertification for in-network providers. HMO members may not have benefits for non-emergency services rendered outside of the network and are subject to review and may be denied.
PPO plans: Precertification for services requiring prior approval is highly recommended. If not completed in advance, a pre-payment review of the claim will occur and may result in a denial of claim reimbursement.
EPO plans: Precertification for services requiring prior approval is highly recommended. If not completed in advance, a pre-payment review of the claim will occur and may result in a denial of claim reimbursement. No out-of-network benefit is available with the exception of ER/urgent care and authorized services.
Requesting precertification with the Virginia plan
To obtain precertification, providers can access Availity* at www.availity.com or call the Utilization Management department using the number on the back of the member’s identification card. Service preapproval is based on member’s benefit plan/eligibility at the time the service is reviewed/approved.
Criteria |
Criteria description |
Codes |
Effective date |
MED.00013 |
Parenteral Antibiotics for the Treatment of Lyme Disease |
96365 |
April 1, 2023 |
MED.00013 |
Parenteral Antibiotics for the Treatment of Lyme Disease |
96372 |
April 1, 2023 |
MED.00013 |
Parenteral Antibiotics for the Treatment of Lyme Disease |
J0456 |
April 1, 2023 |
MED.00013 |
Parenteral Antibiotics for the Treatment of Lyme Disease |
J0696 |
April 1, 2023 |
MED.00013 |
Parenteral Antibiotics for the Treatment of Lyme Disease |
J0698 |
April 1, 2023 |
MED.00013 |
Parenteral Antibiotics for the Treatment of Lyme Disease |
J2540 |
April 1, 2023 |
MED.00013 |
Parenteral Antibiotics for the Treatment of Lyme Disease |
S9494 |
April 1, 2023 |
MED.00013 |
Parenteral Antibiotics for the Treatment of Lyme Disease |
S9497 |
April 1, 2023 |
MED.00013 |
Parenteral Antibiotics for the Treatment of Lyme Disease |
S9504 |
April 1, 2023 |
Featured In:
January 2023 Anthem Provider News - Virginia